Process for the staining of sperm
View Patent ↗Sperm cells are stained according to processes that involve the combining of sperm cells with a fluorescent DNA selective dye at an elevated temperature in excess of about 40° C. The methods allow for a decreased staining time. The cells may thereafter be efficiently sorted according to common separation methods, including flow cytometry.
1. A process for staining sperm cells, the process comprising forming a staining mixture containing intact viable sperm cells and a DNA selective fluorescent dye, and subjecting the staining mixture to a temperature between 41° C. and 47° C. for a period of time sufficient to allow the dye to bind to the DNA without significantly impacting viability of the stained cells.
2. The process of claim 1 , wherein the dye is a UV excitable or a visible light excitable dye.
3. The process of claim 2 , wherein the dye is selected from the group consisting of a bisbenzimide, SYBR-14, and a conjugate, an analog, or a derivative thereof.
4. The process of claim 3 , wherein the dye is selected from the group consisting of Hoechst 33342, Hoechst 33258, SYBR-14, and 6-{[3-((2Z)-2-{[1-(difluoroboryl)-3,5-dimethyl-1H-pyrrol-2-yl]methylene}-2H-pyrrol-5-yl)propanoyl]amino}-N-[3-(methyl{3-[({4-[6-(4-methylpiperazin-1-yl)-1H,3′H-2,5′-bibenzimidazol-2′-yl]phenoxy}acetyl)amino]propyl}amino)propyl]hexanamide.
5. The process of claims 1 , wherein the staining mixture is subjected to the temperature for a period of time sufficient to allow the dye to bind the DNA such that X and Y bearing sperm cells can be differentially sorted based upon fluorescence.
6. The process of claim 5 , wherein the period of time isfrom about 1 minute to about 160 minutes.
7. The process of claim 5 , wherein the period of time is less than about 60 minutes.
8. The process of claim 5 , wherein the period of time is less than about 30 minutes.
9. The process of claim 5 , wherein the dye concentration is from about 0.1 μM to about 1000 μM.
10. The process of claim 9 , wherein the dye concentration is from about 100 μM to about 600 μM.
11. The process of claim 5 , wherein the staining mixture is subjected to a temperature of between 41° C. and 45° C.
12. The process of claim 5 , wherein the staining mixture is subjected to a temperature of between 42° C. and 45° C.
13. The process of claim 5 , wherein the staining mixture is subjected to a temperature of 41° C.
14. The process of claim 5 , wherein the staining mixture is subjected to a temperature of 45° C.
15. The process of claim 5 , wherein the staining mixture is subjected to a temperature of 43° C.
16. The process of claim 1 , wherein the step of forming a staining mixture comprises combining a buffer with the sperm cells.
17. The process of claim 16 , wherein the buffer is combined with the sperm cells to form a sperm suspension, and the sperm suspension is combined with a DNA selective dye to form the staining mixture.
18. The process of claim 1 , wherein the step of forming a staining mixture comprises combining a buffer with a DNA selective dye to form a buffered dye solution, and combining the buffered dye solution with the sperm cells to form the staining mixture.
19. The process of claim 1 , further comprising the step of combining a quencher with the staining mixture.
20. The process of claim 19 , wherein the quencher is selected from the group consisting of FD&C #40 and propidium iodide.
21. The process of claim 20 , wherein the quencher is FD&C #40.
22. The process of claim 20 , wherein the quencher is FD&C #40 and the dye is Hoechst 33342.
23. The process of claim 20 , wherein the quencher is propidium iodide and the dye is SYBR-14.
24. The process of claim 1 , wherein the staining mixture further contains a motility inhibitor.
25. The process of claim 1 , wherein the step of forming a staining mixture comprises combining a motility inhibitor with the sperm cells to form an inhibited sperm suspension, and combining the inhibited sperm suspension with a DNA selective dye to form the staining mixture.
26. The process of claim 25 , wherein the motility inhibitor comprises a carbonate based motility inhibitor.
27. The process of claim 26 , wherein the carbonate based motility inhibitor comprises NaHCO 3 , KHCO 3 , and C 6 H 8 O 7 ·H 2 O.
28. The process of claim 27 , wherein the carbonate based motility inhibitor comprises 0.097 moles/L of NaHCO 3 , 0.173 moles/L of KHCO 3 , 0.090 moles/L C 6 H 8 O 7 ·H 2 O in water.
29. The process of claim 1 , wherein the staining mixture further contains a composition which regulates oxidation/reduction reactions intracellularly or extracellularly.
30. The process of claim 29 , wherein the composition which regulates oxidation/reduction reactions intracellularly or extracellularly is selected from the group consisting of pyruvate, vitamin K, lipoic acid, glutathione, flavins, quinones, superoxide dismutase, and superoxide dismutase mimics.
31. The process of claim 30 , wherein the composition which regulates oxidation/reduction reactions intracellularly or extracellularly is selected from the group consisting of pyruvate, vitamin K, and lipoic acid.
32. The process of claim 31 , wherein the composition which regulates oxidation/reduction reactions intracellularly or extracellularly comprises pyruvate at a concentration from about 0.5 μM to about 50 mM.
33. The process of claim 32 , wherein the composition which regulates oxidation/reduction reactions intracellularly or extracellularly comprises pyruvate at a concentration from about 10 mM to about 15 mM.
34. The process of claim 33 , wherein the composition which regulates oxidation/reduction reactions intracellularly or extracellularly comprises pyruvate at a concentration of about 10 mM.
35. The process of claim 31 , wherein the composition which regulates oxidation/reduction reactions intracellularly or extracellularly comprises vitamin K at a concentration of about 1 μM to about 100 μM.
36. The process of claim 35 , wherein the composition which regulates oxidation/reduction reactions intracellularly or extracellularly comprises vitamin K at a concentration of about 100 μM.
37. The process of claim 31 , wherein the composition which regulates oxidation/reduction reactions intracellularly or extracellularly comprises lipoic acid at a concentration of about 0.1 mM to about 1.0 mM.
38. The process of claim 31 , wherein the composition which regulates oxidation/reduction reactions intracellularly or extracellularly comprises lipoic acid at a concentration of about 1.0 mM.